The following biotech stocks that were featured on our site recently touched new highs yesterday. Did you capitalize on their upward momentum?
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Olema Pharmaceuticals Inc. (OLMA)
Oct.13, 2022
$2.96
$11.15
$10.60
276%
ANI Pharmaceuticals Inc. (ANIP)
May 8, 2023
$42.58
$63.10
$61.08
48%
Phathom Pharmaceuticals Inc. (PHAT)
Jul.10, 2023
$13.98
$16.14
$15.13
15%
Amphastar Pharmaceuticals Inc. (AMPH)
Mar.6, 2023
$35.13
$67.66
$62.21
92%
EyePoint Pharmaceuticals Inc. (EYPT)
Aug.1, 2023
$12.70
$13.46
$13.13
6%
Stevanato Group S.p.A. (STVN)
Feb.24, 2023
$21.36
$36.30
$33.97
70%
InfuSystem Holdings Inc. (INFU)
Feb.6, 2023
$10.47
$11.26
$11.24
7%
Medpace Holdings Inc. (MEDP)
Apr.25, 2023
$208.27
$267.13
$265.47
28%
Reata Pharmaceuticals Inc. (RETA)
Mar.1, 2023
$93.17
$168.70
$167.11
81%
MannKind Corp. (MNKD)
Nov.21, 2022
$4.30
$5.75
$5.34
33%
Tango Therapeutics, Inc. (TNGX)
Jun.13, 2023
$3.63
$9.39
$7.81
158%
(*Last Closing Price refers to the closing price of the stock on Aug.9, 2023)
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.